Clinical Trial Update: Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event

View source ↗

Summary

This completed observational study evaluated whether Crestor 5 mg (rosuvastatin) helps high-risk patients achieve LDL-C target levels.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• CRESTOR (Rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Hypercholesteremia | Status: COMPLETED